[Pharmacokinetics of piperacillin during continuous ambulatory peritoneal dialysis]. 1988

J P Ryckelynck, and D Debruyne, and B Hurault De Ligny, and M Moulin
Service de Néphrologie, CHU Clemenceau, Caen.

We studied the kinetics of piperacillin in patients under continuous ambulatory peritoneal dialysis. Piperacillin 2 g was injected intravenously in 6 patients whereas 1 g was given intraperitoneally either a single dose in 3 patients without infection or the same dose every six-hours in 4 patients with peritonitis. Piperacillin was assayed by HPLC. After intravenous administration, the mean plasma piperacillin concentration was 3.1 +/- 5.6 mg/l at 12 h, the mean plasma t1/2 at 2.43 +/- 0.84 h, the volume of distribution at 20.4 +/- 6.3 l and the peritoneal clearance at 0.19 +/- 0.04 ml/min. After iterative intraperitoneal administration, serum and dialysate concentrations of piperacillin were above the minimum inhibitory concentration for susceptible pathogens without antibiotic accumulation. Peritoneal absorption was higher during peritonitis (83.4 +/- 4.8%) than without peritonitis (67.8 +/- 8.5%). Piperacillin 2 g IV every 8 hours or 1 g IP every 6 hours seemed to be the appropriate regimen in patients with chronic renal failure on CAPD.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D010878 Piperacillin Semisynthetic, broad-spectrum, AMPICILLIN derived ureidopenicillin antibiotic proposed for PSEUDOMONAS infections. It is also used in combination with other antibiotics. AB-Piperacillin,Cl-227193,Pipcil,Pipera-Hameln,Piperacillin Curasan,Piperacillin Fresenius,Piperacillin Hexal,Piperacillin Monosodium Salt,Piperacillin Sodium,Piperacillin-Ratiopharm,Pipercillin,Pipracil,Pipril,T-1220,T1220,AB Piperacillin,Cl 227193,Cl227193,Curasan, Piperacillin,Monosodium Salt, Piperacillin,Pipera Hameln,Piperacillin Ratiopharm,Salt, Piperacillin Monosodium,Sodium, Piperacillin,T 1220
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J P Ryckelynck, and D Debruyne, and B Hurault De Ligny, and M Moulin
October 1996, Clinical pharmacokinetics,
J P Ryckelynck, and D Debruyne, and B Hurault De Ligny, and M Moulin
September 1987, The American journal of cardiology,
J P Ryckelynck, and D Debruyne, and B Hurault De Ligny, and M Moulin
February 1988, Antimicrobial agents and chemotherapy,
J P Ryckelynck, and D Debruyne, and B Hurault De Ligny, and M Moulin
November 1990, The Journal of antimicrobial chemotherapy,
J P Ryckelynck, and D Debruyne, and B Hurault De Ligny, and M Moulin
November 1984, Clinical nephrology,
J P Ryckelynck, and D Debruyne, and B Hurault De Ligny, and M Moulin
January 1985, Therapie,
J P Ryckelynck, and D Debruyne, and B Hurault De Ligny, and M Moulin
January 1989, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
J P Ryckelynck, and D Debruyne, and B Hurault De Ligny, and M Moulin
February 2012, Antimicrobial agents and chemotherapy,
J P Ryckelynck, and D Debruyne, and B Hurault De Ligny, and M Moulin
January 1981, Clinical and experimental dialysis and apheresis,
J P Ryckelynck, and D Debruyne, and B Hurault De Ligny, and M Moulin
January 1987, European journal of clinical pharmacology,
Copied contents to your clipboard!